Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept.

Abstract

Authors

• Zine-Eddine Khene
  Department of Urology, University of Rennes, Rennes, France. zineddine.khene@gmail.com.
• Romain Mathieu
  Department of Urology, CHU Rennes, Rennes, France.
• Benoit Peyronnet
  Department of Urology, Rennes University Hospital, 2, rue Henri Le Guilloux, 35033, Rennes Cedex, France.
• Romain Kokorian
  Department of Medical Oncology, Centre Eugene Marquis, Rennes, France.
• Anis Gasmi
  Department of Urology, Rennes University Hospital, Rennes, France.
• Fares Khene
  Department of Urology, Rennes University Hospital, Rennes, France.
• Nathalie Rioux-Leclercq
  Department of Pathology, Rennes University Hospital, Rennes, France.
• Solène-Florence Kammerer-Jacquet
  Department of Pathology, Rennes University Hospital, Rennes, France.
• Shahrokh Shariat
  Department of Urology, Medical University Vienna, General Hospital, Vienna, Austria.
• Brigitte Laguerre
  Department of Medical Oncology, Centre Eugene Marquis, Rennes, France.
• Karim Bensalah
  Department of Urology, Rennes University Hospital, 2, rue Henri Le Guilloux, 35033, Rennes Cedex, France.

Keywords

External Resources